Cargando…

AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway

The aldo‐keto reductases family 1 member C2 (AKR1C2) has critical roles in the tumorigenesis and progression of malignant tumours. However, it was also discovered to have ambiguous functions in multiple cancers and till present, its clinical significance and molecular mechanism in oesophageal squamo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhan‐Fei, Huang, Tie‐Jun, Zhang, Xin‐Ke, Xie, Yu‐Jie, Lin, Si‐Ting, Luo, Fei‐Fei, Meng, Dong‐Fang, Hu, Hao, Wang, Jing, Peng, Li‐Xia, Qian, Chao‐Nan, Cheng, Chao, Huang, Bi‐Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520259/ https://www.ncbi.nlm.nih.gov/pubmed/32678482 http://dx.doi.org/10.1111/jcmm.15604

Ejemplares similares

Novel long noncoding RNA LINC02820 augments TNF signaling pathway to remodel cytoskeleton and potentiate metastasis in esophageal squamous cell carcinoma
por: Wang, Jing, et al.
Publicado: (2022)

Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma
por: Fan, Zhiqin, et al.
Publicado: (2023)

ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway
por: Yin, Hui, et al.
Publicado: (2020)

Circ0120816 acts as an oncogene of esophageal squamous cell carcinoma by inhibiting miR-1305 and releasing TXNRD1
por: Li, Xiaoyong, et al.
Publicado: (2020)

The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate induced esophageal squamous cell carcinoma cell death
por: Li, Wei, et al.
Publicado: (2016)

AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway
por: Tian, Ke, et al.
Publicado: (2023)

Obesity Potentiates Esophageal Squamous Cell Carcinoma Growth and Invasion by AMPK-YAP Pathway
por: Liu, Jia-Huang, et al.
Publicado: (2020)

The upregulated expression of RFC4 and GMPS mediated by DNA copy number alteration is associated with the early diagnosis and immune escape of ESCC based on a bioinformatic analysis
por: Wang, Jing, et al.
Publicado: (2021)

Expression of AKR1C3, β-Catenin and LEF1 in Esophageal Squamous Cell Carcinoma and the Relationship with Radiation Resistance
por: Xiong, Wei, et al.
Publicado: (2021)

A novel pyroptosis scoring model was associated with the prognosis and immune microenvironment of esophageal squamous cell carcinoma
por: Zhang, Zhan-Fei
Publicado: (2023)

HMGB1 induces radioresistance through PI3K/AKT/ATM pathway in esophageal squamous cell carcinoma
por: Zhang, Xueyuan, et al.
Publicado: (2022)

EXOC3L1: A Novel Prognostic Biomarker Correlated with Immune Infiltration in Esophageal Squamous Cell Carcinoma
por: Zhang, Zhan-Fei
Publicado: (2023)

Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway
por: Guo, Jida, et al.
Publicado: (2022)

Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma
por: Shen, Zhimin, et al.
Publicado: (2020)

AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway
por: Qu, Jiayao, et al.
Publicado: (2021)

EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma
por: Bi, Yanghui, et al.
Publicado: (2019)

Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway
por: Guo, Jida, et al.
Publicado: (2022)

Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinoma
por: Sun, Peng, et al.
Publicado: (2016)

circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway
por: Zhou, Shifan, et al.
Publicado: (2021)

PRR14 acts a novel oncogene activating the PI3K signal pathway in human cutaneous squamous cell carcinoma
por: Zhang, Lili, et al.
Publicado: (2023)

CDCA2 acts as an oncogene and induces proliferation of clear cell renal cell carcinoma cells
por: Li, Fang, et al.
Publicado: (2020)

PBF, a Proto-oncogene in Esophageal Carcinoma
por: Lian, Shi-hai, et al.
Publicado: (2019)

Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K/Akt pathway
por: ZHANG, HONG-BO, et al.
Publicado: (2013)

Xuebijing injection protects against sepsis-induced myocardial injury by regulating apoptosis and autophagy via mediation of PI3K/AKT/mTOR signaling pathway in rats
por: Bi, Cheng-Fei, et al.
Publicado: (2023)

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma
por: Cao, Yu-Fei, et al.
Publicado: (2022)

HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma
por: Wu, Xiang, et al.
Publicado: (2021)

MicroRNA-206 exerts anti-oncogenic functions in esophageal squamous cell carcinoma by suppressing the c-Met/AKT/mTOR pathway
por: Zhang, Jin, et al.
Publicado: (2019)

GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner
por: Lin, Fen, et al.
Publicado: (2019)

HBV Infection-Related PDZK1 Plays an Oncogenic Role by Regulating the PI3K-Akt Pathway and Fatty Acid Metabolism and Enhances Immunosuppression
por: Chen, Xin, et al.
Publicado: (2022)

The autoregulatory serglycin/CD44 axis drives stemness‐like phenotypes in TNBC in a β‐catenin‐dependent manner
por: Cao, Li, et al.
Publicado: (2021)

Expression of P-EGFR and P-Akt protein in esophageal squamous cell carcinoma and its prognosis
por: Shan, Zheng-Zheng, et al.
Publicado: (2017)

LLGL2 Increases Ca(2+) Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma
por: Leng, Shusheng, et al.
Publicado: (2021)

MOB kinase activator 1A acts as an oncogene by targeting PI3K/AKT/mTOR in ovarian cancer
por: Lei, Jian, et al.
Publicado: (2023)

miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway
por: Zheng, Tian-Liang, et al.
Publicado: (2019)

Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway
por: Qiao, Zhongshi, et al.
Publicado: (2022)

Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasis
por: Ye, Bo, et al.
Publicado: (2021)

Irisin functions to inhibit malignant growth of human pancreatic cancer cells via downregulation of the PI3K/AKT signaling pathway
por: Zhang, Deguo, et al.
Publicado: (2019)

PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling
por: Wang, Mengmeng, et al.
Publicado: (2023)

The expression and significance of AKR1B10 in laryngeal squamous cell carcinoma
por: Liu, Jixuan, et al.
Publicado: (2021)

Up-regulation of SOCS4 promotes cell proliferation and migration in esophageal squamous cell carcinoma
por: Ying, Jie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1ab3fl2rdsl2n4k0n9l7ollamj